Akums Drugs & Pharmaceuticals Ltd.
ShareAKUMS Competitor Analysis
| AKUMS | SUNPHARMA  | DIVISLAB | TORNTPHARM | CIPLA | |
|---|---|---|---|---|---|
Overview | |||||
| Current price (₹) As on 30 Sept, 2025, 03:54 PM | 441.45 -0.51% | 1,594.30 0.31% | 5,689.50 -0.14% | 3,603.20 0.46% | 1,503.30 1.03% |
| Market cap (₹ Cr) | 6,948 | 3,82,526 | 1,51,038 | 1,21,949 | 1,21,430 |
Report Card | |||||
| Quality | |||||
| Growth | |||||
| Momentum | |||||
| Value | |||||
Past ReturnsAbsolute Returns Shown | |||||
| 1D | -0.66% | 0.16% | 0.14% | 0.72% | -0.76% |
| 1W | -5.73% | -2.57% | -5.84% | -1.78% | -2.56% |
| 1M | -2.32% | -0.33% | -7.08% | 0.75% | -6.38% |
| 3M | -24.21% | -5.16% | -16.33% | 5.23% | -1.19% |
| 6M | -6.23% | -8.38% | -1.35% | 11.11% | 3.18% |
| 1Y | -46.92% | -17.51% | 4.67% | 5.6% | -10.04% |
| 5Y | -- | 217.57% | 86.93% | 156.19% | 92.07% |
Income StatementAnnual data as on 30 Sept 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Sales | 4,118 -1.44% | 52,578 8.41% | 9,360 19.31% | 11,516 7.35% | 27,548 6.88% |
| OPM (%) | 11.14 281.51% | 28 7.2% | 30.56 13.44% | 32.25 3.3% | 25.09 5.78% |
| PBT | 345.25 862.48% | 13,752 24.03% | 2,916 34.81% | 2,673 13.65% | 6,821 19.62% |
PAT | 343.78 43416.46% | 10,980 13.81% | 2,191 36.94% | 1,911 15.4% | 5,291 27.34% |
| Net Profit Margin | 8.35 41650% | 20.85 5.2% | 23.41 14.75% | 16.6 7.51% | 19.13 18.67% |
| EPS | 21.49 7775% | 45.55 14.13% | 82.53 36.93% | 56.47 15.39% | 65.28 27.87% |
Balance Sheet & Cash FlowAnnual data as on 30 Sept 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Net Worth | 3,047 329.46% | 72,218 13.43% | 14,969 10.3% | 7,591 10.72% | 31,193 16.8% |
| Total Assets | 4,113 16.98% | 92,101 7.77% | 16,932 9.45% | 14,990 -0.47% | 37,387 14.27% |
| Total Outside Liabilities | 1,066 -62.02% | 19,883 -8.78% | 1,963 3.37% | 7,399 -9.81% | 6,194 3.04% |
| Cash from Operating Activity | 465.2 -6.64% | 14,072 15.96% | 1,653 31.09% | 2,585 -20.85% | 5,005 21.07% |
| Cash from Investment Activity | -547.84 -65.8% | -5,306 -668.76% | -804 -198.88% | -540.05 -221.65% | -3,691 -23.53% |
| Cash from Financing Activity | 72.79 167.39% | -7,906 -17.82% | -799 0% | -2,298 17.34% | -1,293 -7.75% |
| Net Cash Flow | -9.86 -116.48% | 983.12 -78.91% | 50 -74.09% | -261.66 -180.11% | 30.31 161.87% |
RatiosAnnual data as on 30 Sept 2025. | |||||
| PB | 2.38 | 5.77 | 10.22 | 14.42 | 3.73 |
| PE | 20.55 | 35.00 | 68.94 | 63.81 | 23.03 |
| ROE (%) | 18.30 | 16.16 | 15.35 | 26.46 | 18.28 |
| Dividend Yield (%) | 0 | 1.00 | 0.53 | 0.89 | 1.06 |
| ROCE (%) | 17.04 | 20.86 | 20.45 | 27.55 | 23.64 |
